spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioPharm America™ 2017—10th Annual International Partnering Conference

26-27 September 2017
39 Dalton Street, Boston, MA 02116

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Now in its tenth year, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size and stage, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.

A primary focus of BioPharm America™ is the one-to-one meetings driven by partneringONE®, the industry’s most robust software platform. Delegates can request and schedule meetings tailored to their strategic business goals to create a dynamic personalized agenda that includes regular alerts for further meeting opportunities.
The impetus behind this intensive business development activity is a two-day conference program that features thought leaders and executives from across the life science industry. To help bring attention to early stage projects and small entrepreneurial companies, BioPharm America features special tracks specifically designed for startups and young companies to get on the radar of the global life science community and to make the connections that matter. Engaging panel discussions cover topics of interest to dealmakers including licensing, investment and business development.

Leading pharmaceutical companies attend BioPharm America in search of innovation, such as Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Boehringer Ingelheim, Genentech, Sanofi/Genzyme, Gilead, Ironwood, Johnson & Johnson Innovation, Merck, Novo Nordisk, Nycomed, Pfizer, and Shire. Held in Boston each September, the event attracted 850+ delegates from 525 companies who participated in 2,350+ scheduled one-to-one meetings in 2016.

For more information and online registration please visit our conference website at https://ebdgroup.knect365.com/biopharm-america

Producer:
EBD Group, Inc.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

Contact:
Cassidy Hamilton
EBD Group
Carlsbad, CA
+1 760 930 0500
chamilton@ebdgroup.com

Industry:
Biotech

Key words:
partnering, early stage, investing, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
Intended for:

Top international executives from:

    Established and emerging biotech companies
    Pharmaceutical companies
    Institutional financial firms
    Private investors including venture capital and private equity firms
    Startup Biotech Companies (via Startup program)
    Scientists / Researches (via Charles River Track)


Speakers:
https://ebdgroup.knect365.com/biopharm-america/speakers

Cost:
https://ebdgroup.knect365.com/biopharm-america/registration-information

Program:
https://ebdgroup.knect365.com/biopharm-america/agenda/1
 
Print this page
Send to a friend
   
spacer
Industry Events

SMI Immuno-Oncology Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>


News and Press Releases

PPMA Group Industry Awards 2018 Call for Entries – Deadline 31st July

The PPMA Group Industry Awards, which recognise manufacturing excellence, technical innovation, entrepreneurship as well as outstanding achievement and contribution to the industry, will this year take place at a new venue – the Hilton Birmingham Metropole Hotel at the NEC - on the 25th September 2018.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement